mechlorethamine has been researched along with Persistent Fetal Circulation Syndrome in 1 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cech, P | 1 |
| Testa, U | 1 |
| Dubart, A | 1 |
| Schneider, P | 1 |
| Bachmann, F | 1 |
| Guerrasio, A | 1 |
| Beuzard, Y | 1 |
| Schmidt, PM | 1 |
| Clément, F | 1 |
| Rosa, J | 1 |
1 other study available for mechlorethamine and Persistent Fetal Circulation Syndrome
| Article | Year |
|---|---|
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin | 1982 |